List of Figures |
Figure 1‑1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2) |
4 |
Figure 1‑2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2) |
4 |
Figure 1‑3: Companies Researched in This Report (1 of 2) |
5 |
Figure 1‑4: Companies Researched in This Report (2 of 2) |
6 |
Figure 1‑5: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (1 of 2) |
7 |
Figure 1‑6: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (2 of 2) |
8 |
Figure 1‑7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2) |
9 |
Figure 1‑8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2) |
10 |
Figure 1‑9: Interventional Cardiology Device Procedures Covered |
11 |
Figure 1‑10: Interventional Cardiology Device Markets Covered |
12 |
Figure 1‑11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2) |
13 |
Figure 1‑12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2) |
14 |
Figure 1‑13: Version History |
15 |
Figure 2‑1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
34 |
Figure 2‑2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
35 |
Figure 2‑3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
36 |
Figure 2‑4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
37 |
Figure 2‑5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2) |
38 |
Figure 2‑6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2) |
39 |
Figure 4‑1: Coronary Stents by Company |
50 |
Figure 4‑2: Coronary Balloon Catheters by Company |
52 |
Figure 4‑3: Interventional Coronary Catheters by Company |
54 |
Figure 4‑4: Interventional Coronary Guidewires by Company |
56 |
Figure 4‑5: Coronary Embolic Protection Devices by Company |
58 |
Figure 4‑6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company |
60 |
Figure 4‑7: Coronary Introducer Sheaths by Company (1 of 2) |
62 |
Figure 4‑8: Coronary Introducer Sheaths by Company (2 of 2) |
63 |
Figure 4‑9: Coronary Vascular Closure Devices by Company |
65 |
Figure 4‑10: Diagnostic Coronary Catheters & Guidewires by Company |
67 |
Figure 4‑11: Coronary Intravascular Ultrasound Devices by Company |
69 |
Figure 4‑12: Coronary Optical Coherence Tomography by Company |
71 |
Figure 4‑13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System |
72 |
Figure 4‑14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm |
72 |
Figure 4‑15: Class 2 Device Recall Cordis Precise Nitinol Stent System |
72 |
Figure 4‑16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System |
73 |
Figure 4‑17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System |
73 |
Figure 4‑18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter |
74 |
Figure 4‑19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter |
74 |
Figure 4‑20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters |
75 |
Figure 4‑21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter |
75 |
Figure 4‑22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter |
75 |
Figure 4‑23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter |
75 |
Figure 4‑24: Class 2 Device Recall MAMBA Flex 135 Microcatheter |
76 |
Figure 4‑25: Class 2 Device Recall MAMBA Microcatheter |
76 |
Figure 4‑26: Class 2 Device Recall Guidezilla II Guide Extension Catheter |
76 |
Figure 4‑27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER |
77 |
Figure 4‑28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter |
77 |
Figure 4‑29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters |
77 |
Figure 4‑30: Class 1 Device Recall 6F Taiga Guiding Catheter |
78 |
Figure 4‑31: Class 2 Device Recall Destination Guiding Sheath |
78 |
Figure 4‑32: Class 2 Device Recall Stingray" Guidewire |
79 |
Figure 4‑33: Class 1 Device Recall TurboHawk Plus |
80 |
Figure 4‑34: Class 1 Device Recall HawkOne |
80 |
Figure 4‑35: Class 2 Device Recall Boston Scientific ROTAPRO |
80 |
Figure 4‑36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM |
80 |
Figure 4‑37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER |
81 |
Figure 4‑38: Class 2 Device Recall |
81 |
Figure 4‑39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification |
81 |
Figure 4‑40: Class 2 Device Recall Prelude Short Sheath Introducer |
82 |
Figure 4‑41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer |
82 |
Figure 4‑42: Class 2 Device Recall Avanti Catheter Sheath Introducer |
82 |
Figure 4‑43: Class 1 Device Recall Flexor CheckFlo Introducer |
82 |
Figure 4‑44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS |
83 |
Figure 4‑45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER |
83 |
Figure 4‑46: Class 1 Device Recall Portico Solo ReCollapsible Access System |
83 |
Figure 4‑47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System |
83 |
Figure 4‑48: Class 2 Device Recall Microintroducer Kit |
84 |
Figure 4‑49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices |
85 |
Figure 4‑50: Class 2 Device Recall AngioSeal Evolution |
85 |
Figure 4‑51: Class 1 Device Recall Imager II 5F Angiographic Catheter |
86 |
Figure 4‑52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter |
87 |
Figure 4‑53: Class 2 Device Recall iLab Polaris MultiModality Guidance System |
87 |
Figure 4‑54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN) |
89 |
Figure 4‑55: RESOLUTE ONYX China Single Arm Study |
89 |
Figure 4‑56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48) |
90 |
Figure 4‑57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System |
90 |
Figure 4‑58: PROMUS PREMIER™ China Post-Approval Study |
91 |
Figure 4‑59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) |
91 |
Figure 4‑60: China Resolute Integrity 34/38 mm Study |
92 |
Figure 4‑61: ILUMIEN IV: OPTIMAL PCI |
92 |
Figure 4‑62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort) |
93 |
Figure 4‑63: RESOLUTE ONYX Post-Approval Study (ONYX PAS) |
93 |
Figure 4‑64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V) |
94 |
Figure 4‑65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48) |
94 |
Figure 4‑66: Sirolimus DEB in Coronary Bifurcation Lesions |
95 |
Figure 4‑67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV) |
95 |
Figure 4‑68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF) |
96 |
Figure 4‑69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST) |
96 |
Figure 4‑70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater |
97 |
Figure 4‑71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I) |
97 |
Figure 4‑72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease |
97 |
Figure 4‑73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases |
98 |
Figure 4‑74: FIRE AND ICE II Trial Pilot |
99 |
Figure 4‑75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD) |
99 |
Figure 4‑76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First) |
100 |
Figure 4‑77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI) |
101 |
Figure 4‑78: Pressure Guidewire Comparison |
101 |
Figure 4‑79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2) |
102 |
Figure 4‑80: transShield Embolic Protection System Feasibility Study |
102 |
Figure 4‑81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation |
103 |
Figure 4‑82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis |
103 |
Figure 4‑83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s |
104 |
Figure 4‑84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT) |
104 |
Figure 4‑85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT) |
105 |
Figure 4‑86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD) |
105 |
Figure 4‑87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial |
106 |
Figure 4‑88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF) |
106 |
Figure 4‑89: Application of Vascular Closure Device in Transvenous Cardiac Intervention |
107 |
Figure 4‑90: Comparison of Different Vascular Closure Device in TAVI |
107 |
Figure 4‑91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease |
108 |
Figure 4‑92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE) |
108 |
Figure 4‑93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial |
109 |
Figure 4‑94: Vascular Closure Device in Transcatheter Aortic Valve Replacement |
109 |
Figure 4‑95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) |
110 |
Figure 4‑96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES) |
110 |
Figure 4‑97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System |
111 |
Figure 4‑98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA) |
111 |
Figure 4‑99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER) |
112 |
Figure 4‑100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS) |
112 |
Figure 4‑101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP) |
113 |
Figure 4‑102: The OPTIMAL Randomized Controlled Trial |
113 |
Figure 4‑103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite) |
114 |
Figure 4‑104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES) |
114 |
Figure 4‑105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS) |
115 |
Figure 4‑106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB) |
116 |
Figure 4‑107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography |
116 |
Figure 4‑108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM) |
117 |
Figure 4‑109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging |
117 |
Figure 5‑1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2) |
123 |
Figure 5‑2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2) |
124 |
Figure 5‑3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M) |
128 |
Figure 5‑4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2) |
139 |
Figure 5‑5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2) |
140 |
Figure 5‑6: SWOT Analysis, Abbott (1 of 2) |
155 |
Figure 5‑7: SWOT Analysis, Abbott (2 of 2) |
156 |
Figure 5‑8: SWOT Analysis, Asahi Intecc |
157 |
Figure 5‑9: SWOT Analysis, Boston Scientific |
158 |
Figure 5‑10: SWOT Analysis, Cordis |
159 |
Figure 5‑11: SWOT Analysis, Cook Medical |
160 |
Figure 5‑12: SWOT Analysis, Medtronic |
161 |
Figure 5‑13: SWOT Analysis, Penumbra |
162 |
Figure 5‑14: SWOT Analysis, Philips |
163 |
Figure 5‑15: SWOT Analysis, Teleflex |
164 |
Figure 5‑16: SWOT Analysis, Terumo |
165 |
Figure 6‑1: Coronary Stent Procedures Covered |
169 |
Figure 6‑2: Coronary Stent Markets Covered |
170 |
Figure 6‑3: Coronary Stent Regions Covered, Global (1 of 2) |
171 |
Figure 6‑4: Coronary Stent Regions Covered, Global (2 of 2) |
172 |
Figure 6‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 |
176 |
Figure 6‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 |
178 |
Figure 6‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
179 |
Figure 6‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
180 |
Figure 6‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 |
181 |
Figure 6‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
182 |
Figure 6‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
183 |
Figure 6‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 |
184 |
Figure 6‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
185 |
Figure 6‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
186 |
Figure 6‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
187 |
Figure 6‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 |
188 |
Figure 6‑17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M) |
190 |
Figure 6‑18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M) |
192 |
Figure 6‑19: Total Coronary Stent Market, Global, 2019 – 2029 |
194 |
Figure 6‑20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029 |
195 |
Figure 6‑21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$) |
196 |
Figure 6‑22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M) |
197 |
Figure 6‑23: Bare-Metal Stent Market, Global, 2019 – 2029 |
198 |
Figure 6‑24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029 |
199 |
Figure 6‑25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$) |
200 |
Figure 6‑26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M) |
201 |
Figure 6‑27: Drug-Eluting Stent Market, Global, 2019 – 2029 |
202 |
Figure 6‑28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 |
203 |
Figure 6‑29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$) |
204 |
Figure 6‑30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M) |
205 |
Figure 6‑31: Leading Competitors, Coronary Stent Market, Global, 2022 |
211 |
Figure 7‑1: Coronary Balloon Catheter Procedures Covered |
217 |
Figure 7‑2: Coronary Balloon Catheter Markets Covered |
218 |
Figure 7‑3: Coronary Balloon Catheter Regions Covered, Global (1 of 2) |
219 |
Figure 7‑4: Coronary Balloon Catheter Regions Covered, Global (2 of 2) |
220 |
Figure 7‑5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 |
224 |
Figure 7‑6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 |
226 |
Figure 7‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
227 |
Figure 7‑8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
228 |
Figure 7‑9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 |
229 |
Figure 7‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
230 |
Figure 7‑11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
231 |
Figure 7‑12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 |
232 |
Figure 7‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
233 |
Figure 7‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
234 |
Figure 7‑15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
235 |
Figure 7‑16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 |
236 |
Figure 7‑17: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029 (US$M) |
238 |
Figure 7‑18: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029 (US$M) |
240 |
Figure 7‑19: Total Coronary Balloon Catheter Market, Global, 2019 – 2029 |
242 |
Figure 7‑20: Units Sold by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 |
243 |
Figure 7‑21: Average Selling Price by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$) |
244 |
Figure 7‑22: Market Value by Region, Total Coronary Balloon Catheter Market, Global, 2019 – 2029 (US$M) |
245 |
Figure 7‑23: PTCA Balloon Catheter Market, Global, 2019 – 2029 |
246 |
Figure 7‑24: Units Sold by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 |
247 |
Figure 7‑25: Average Selling Price by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$) |
248 |
Figure 7‑26: Market Value by Region, PTCA Balloon Catheter Market, Global, 2019 – 2029 (US$M) |
249 |
Figure 7‑27: Specialty Balloon Catheter Market, Global, 2019 – 2029 |
250 |
Figure 7‑28: Units Sold by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 |
251 |
Figure 7‑29: Average Selling Price by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$) |
252 |
Figure 7‑30: Market Value by Region, Specialty Balloon Catheter Market, Global, 2019 – 2029 (US$M) |
253 |
Figure 7‑31: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022 |
258 |
Figure 8‑1: Interventional Coronary Catheter Procedures Covered |
263 |
Figure 8‑2: Interventional Coronary Catheter Regions Covered, Global (1 of 2) |
264 |
Figure 8‑3: Interventional Coronary Catheter Regions Covered, Global (2 of 2) |
265 |
Figure 8‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 |
268 |
Figure 8‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 |
270 |
Figure 8‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
271 |
Figure 8‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
272 |
Figure 8‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 |
273 |
Figure 8‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
274 |
Figure 8‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
275 |
Figure 8‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 |
276 |
Figure 8‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
277 |
Figure 8‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
278 |
Figure 8‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
279 |
Figure 8‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 |
280 |
Figure 8‑16: Interventional Coronary Catheter Market, Global, 2019 – 2029 |
281 |
Figure 8‑17: Units Sold by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 |
282 |
Figure 8‑18: Average Selling Price by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$) |
283 |
Figure 8‑19: Market Value by Region, Interventional Coronary Catheter Market, Global, 2019 – 2029 (US$M) |
284 |
Figure 8‑20: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022 |
289 |
Figure 9‑1: Interventional Coronary Guidewire Procedures Covered |
294 |
Figure 9‑2: Interventional Coronary Guidewire Regions Covered, Global (1 of 2) |
295 |
Figure 9‑3: Interventional Coronary Guidewire Regions Covered, Global (2 of 2) |
296 |
Figure 9‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 |
299 |
Figure 9‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 |
301 |
Figure 9‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
302 |
Figure 9‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
303 |
Figure 9‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 |
304 |
Figure 9‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
305 |
Figure 9‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
306 |
Figure 9‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 |
307 |
Figure 9‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
308 |
Figure 9‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
309 |
Figure 9‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
310 |
Figure 9‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 |
311 |
Figure 9‑16: Interventional Coronary Guidewire Market, Global, 2019 – 2029 |
312 |
Figure 9‑17: Units Sold by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 |
313 |
Figure 9‑18: Average Selling Price by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$) |
314 |
Figure 9‑19: Market Value by Region, Interventional Coronary Guidewire Market, Global, 2019 – 2029 (US$M) |
315 |
Figure 9‑20: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022 |
320 |
Figure 10‑1: Coronary Embolic Protection Device Regions Covered, Global (1 of 2) |
326 |
Figure 10‑2: Coronary Embolic Protection Device Regions Covered, Global (2 of 2) |
327 |
Figure 10‑3: Coronary Embolic Protection Device Market, Global, 2019 – 2029 |
330 |
Figure 10‑4: Units Sold by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 |
331 |
Figure 10‑5: Average Selling Price by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$) |
332 |
Figure 10‑6: Market Value by Region, Coronary Embolic Protection Device Market, Global, 2019 – 2029 (US$M) |
333 |
Figure 10‑7: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022 |
337 |
Figure 11‑1: Atherectomy and IVL Device Procedures Covered |
343 |
Figure 11‑2: Atherectomy and IVL Device Regions Covered, Global (1 of 2) |
344 |
Figure 11‑3: Atherectomy and IVL Device Regions Covered, Global (2 of 2) |
345 |
Figure 11‑4: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029 |
348 |
Figure 11‑5: Coronary Atherectomy and IVL Procedures by Country, North America, 2019 – 2029 |
350 |
Figure 11‑6: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
351 |
Figure 11‑7: Coronary Atherectomy and IVL Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
352 |
Figure 11‑8: Coronary Atherectomy and IVL Procedures by Country, Western Europe, 2019 – 2029 |
353 |
Figure 11‑9: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
354 |
Figure 11‑10: Coronary Atherectomy and IVL Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
355 |
Figure 11‑11: Coronary Atherectomy and IVL Procedures by Country, Middle East, 2019 – 2029 |
356 |
Figure 11‑12: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
357 |
Figure 11‑13: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
358 |
Figure 11‑14: Coronary Atherectomy and IVL Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
359 |
Figure 11‑15: Coronary Atherectomy and IVL Procedures by Country, Africa, 2019 – 2029 |
360 |
Figure 11‑16: Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 |
361 |
Figure 11‑17: Units Sold by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 |
362 |
Figure 11‑18: Average Selling Price by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$) |
363 |
Figure 11‑19: Market Value by Region, Coronary Atherectomy and IVL Device Market, Global, 2019 – 2029 (US$M) |
364 |
Figure 11‑20: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022 |
368 |
Figure 12‑1: Coronary Introducer Sheath Procedures Covered |
374 |
Figure 12‑2: Coronary Introducer Sheath Regions Covered, Global (1 of 2) |
375 |
Figure 12‑3: Coronary Introducer Sheath Regions Covered, Global (2 of 2) |
376 |
Figure 12‑4: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029 |
380 |
Figure 12‑5: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029 |
382 |
Figure 12‑6: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
383 |
Figure 12‑7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
384 |
Figure 12‑8: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029 |
385 |
Figure 12‑9: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
386 |
Figure 12‑10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
387 |
Figure 12‑11: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029 |
388 |
Figure 12‑12: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
389 |
Figure 12‑13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
390 |
Figure 12‑14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
391 |
Figure 12‑15: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029 |
392 |
Figure 12‑16: Coronary Introducer Sheath Market, Global, 2019 – 2029 |
393 |
Figure 12‑17: Units Sold by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 |
394 |
Figure 12‑18: Average Selling Price by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$) |
395 |
Figure 12‑19: Market Value by Region, Coronary Introducer Sheath Market, Global, 2019 – 2029 (US$M) |
396 |
Figure 12‑20: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022 |
402 |
Figure 13‑1: Coronary Vascular Closure Device Procedures Covered |
407 |
Figure 13‑2: Coronary Vascular Closure Device Markets Covered |
408 |
Figure 13‑3: Coronary Vascular Closure Device Regions Covered, Global (1 of 2) |
409 |
Figure 13‑4: Coronary Vascular Closure Device Regions Covered, Global (2 of 2) |
410 |
Figure 13‑5: Total Catheterization Procedures by Region, Global, 2019 – 2029 |
413 |
Figure 13‑6: Catheterization Procedures by Country, North America, 2019 – 2029 |
415 |
Figure 13‑7: Catheterization Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
416 |
Figure 13‑8: Catheterization Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
417 |
Figure 13‑9: Catheterization Procedures by Country, Western Europe, 2019 – 2029 |
418 |
Figure 13‑10: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
419 |
Figure 13‑11: Catheterization Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
420 |
Figure 13‑12: Catheterization Procedures by Country, Middle East, 2019 – 2029 |
421 |
Figure 13‑13: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
422 |
Figure 13‑14: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
423 |
Figure 13‑15: Catheterization Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
424 |
Figure 13‑16: Catheterization Procedures by Country, Africa, 2019 – 2029 |
425 |
Figure 13‑17: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029 (US$M) |
427 |
Figure 13‑18: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029 (US$M) |
429 |
Figure 13‑19: Coronary Vascular Closure Device Market, Global, 2019 – 2029 |
432 |
Figure 13‑20: Units Sold by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 |
433 |
Figure 13‑21: Average Selling Price by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$) |
434 |
Figure 13‑22: Market Value by Region, Coronary Vascular Closure Device Market, Global, 2019 – 2029 (US$M) |
435 |
Figure 13‑23: Invasive VCD Market, Global, 2019 – 2029 |
436 |
Figure 13‑24: Units Sold by Region, Invasive VCD Market, Global, 2019 – 2029 |
437 |
Figure 13‑25: Average Selling Price by Region, Invasive VCD Market, Global, 2019 – 2029 (US$) |
438 |
Figure 13‑26: Market Value by Region, Invasive VCD Market, Global, 2019 – 2029 (US$M) |
439 |
Figure 13‑27: Non-Invasive VCD Market, Global, 2019 – 2029 |
440 |
Figure 13‑28: Units Sold by Region, Non-Invasive VCD Market, Global, 2019 – 2029 |
441 |
Figure 13‑29: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$) |
442 |
Figure 13‑30: Market Value by Region, Non-Invasive VCD Market, Global, 2019 – 2029 (US$M) |
443 |
Figure 13‑31: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022 |
448 |
Figure 14‑1: Diagnostic Catheter and Guidewire Procedures Covered |
454 |
Figure 14‑2: Diagnostic Catheter and Guidewire Markets Covered |
455 |
Figure 14‑3: Diagnostic Catheter and Guidewire Regions Covered, Global (1 of 2) |
456 |
Figure 14‑4: Diagnostic Catheter and Guidewire Regions Covered, Global (2 of 2) |
457 |
Figure 14‑5: Total Diagnostic Catheter and Guidewire Procedures by Segment, Global, 2019 – 2029 |
459 |
Figure 14‑6: Angiography Procedures by Region, Global, 2019 – 2029 |
461 |
Figure 14‑7: Angiography Procedures by Country, North America, 2019 – 2029 |
463 |
Figure 14‑8: Angiography Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
464 |
Figure 14‑9: Angiography Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
465 |
Figure 14‑10: Angiography Procedures by Country, Western Europe, 2019 – 2029 |
466 |
Figure 14‑11: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
467 |
Figure 14‑12: Angiography Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
468 |
Figure 14‑13: Angiography Procedures by Country, Middle East, 2019 – 2029 |
469 |
Figure 14‑14: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
470 |
Figure 14‑15: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
471 |
Figure 14‑16: Angiography Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
472 |
Figure 14‑17: Angiography Procedures by Country, Africa, 2019 – 2029 |
473 |
Figure 14‑18: FFR Guidewire Procedures by Region, Global, 2019 – 2029 |
475 |
Figure 14‑19: FFR Guidewire Procedures by Country, North America, 2019 – 2029 |
477 |
Figure 14‑20: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
478 |
Figure 14‑21: FFR Guidewire Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
479 |
Figure 14‑22: FFR Guidewire Procedures by Country, Western Europe, 2019 – 2029 |
480 |
Figure 14‑23: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
481 |
Figure 14‑24: FFR Guidewire Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
482 |
Figure 14‑25: FFR Guidewire Procedures by Country, Middle East, 2019 – 2029 |
483 |
Figure 14‑26: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
484 |
Figure 14‑27 FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
485 |
Figure 14‑28: FFR Guidewire Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
486 |
Figure 14‑29: FFR Guidewire Procedures by Country, Africa, 2019 – 2029 |
487 |
Figure 14‑30: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029 (US$M) |
489 |
Figure 14‑31: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029 (US$M) |
491 |
Figure 14‑32: Total Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 |
493 |
Figure 14‑33: Units Sold by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 |
494 |
Figure 14‑34: Average Selling Price by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$) |
495 |
Figure 14‑35: Market Value by Region, Diagnostic Catheter and Guidewire Market, Global, 2019 – 2029 (US$M) |
496 |
Figure 14‑36: Interventional Diagnostic Catheter Market, Global, 2019 – 2029 |
497 |
Figure 14‑37: Units Sold by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 |
498 |
Figure 14‑38: Average Selling Price by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$) |
499 |
Figure 14‑39: Market Value by Region, Interventional Diagnostic Catheter Market, Global, 2019 – 2029 (US$M) |
500 |
Figure 14‑40: Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 |
501 |
Figure 14‑41: Units Sold by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 |
502 |
Figure 14‑42: Average Selling Price by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$) |
503 |
Figure 14‑43: Market Value by Region, Interventional Diagnostic Guidewire Market, Global, 2019 – 2029 (US$M) |
504 |
Figure 14‑44: FFR Guidewire Market, Global, 2019 – 2029 |
505 |
Figure 14‑45: Units Sold by Region, FFR Guidewire Market, Global, 2019 – 2029 |
506 |
Figure 14‑46: Average Selling Price by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$) |
507 |
Figure 14‑47: Market Value by Region, FFR Guidewire Market, Global, 2019 – 2029 (US$M) |
508 |
Figure 14‑48: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022 |
514 |
Figure 15‑1: OCT Catheter Procedures Covered |
519 |
Figure 15‑2: OCT Catheter Regions Covered, Global (1 of 2) |
520 |
Figure 15‑3: OCT Catheter Regions Covered, Global (2 of 2) |
521 |
Figure 15‑4: OCT Procedures by Region, Global, 2019 – 2029 |
525 |
Figure 15‑5: OCT Procedures by Country, North America, 2019 – 2029 |
527 |
Figure 15‑6: OCT Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
528 |
Figure 15‑7: OCT Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
529 |
Figure 15‑8: OCT Procedures by Country, Western Europe, 2019 – 2029 |
530 |
Figure 15‑9: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
531 |
Figure 15‑10: OCT Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
532 |
Figure 15‑11: OCT Procedures by Country, Middle East, 2019 – 2029 |
533 |
Figure 15‑12: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
534 |
Figure 15‑13: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
535 |
Figure 15‑14: OCT Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
536 |
Figure 15‑15: OCT Procedures by Country, Africa, 2019 – 2029 |
537 |
Figure 15‑16: OCT Catheter Market, Global, 2019 – 2029 |
538 |
Figure 15‑17: Units Sold by Region, OCT Catheter Market, Global, 2019 – 2029 |
539 |
Figure 15‑18: Average Selling Price by Region, OCT Catheter Market, Global, 2019 – 2029 (US$) |
540 |
Figure 15‑19: Market Value by Region, OCT Catheter Market, Global, 2019 – 2029 (US$M) |
541 |
Figure 15‑20: Leading Competitors, OCT Catheter Market, Global, 2022 |
545 |
Figure 16‑1: IVUS Catheter Procedures Covered |
550 |
Figure 16‑2: IVUS Catheter Regions Covered, Global (1 of 2) |
551 |
Figure 16‑3: IVUS Catheter Regions Covered, Global (2 of 2) |
552 |
Figure 16‑4: IVUS Procedures by Region, Global, 2019 – 2029 |
555 |
Figure 16‑5: IVUS Procedures by Country, North America, 2019 – 2029 |
557 |
Figure 16‑6: IVUS Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
558 |
Figure 16‑7: IVUS Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
559 |
Figure 16‑8: IVUS Procedures by Country, Western Europe, 2019 – 2029 |
560 |
Figure 16‑9: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
561 |
Figure 16‑10: IVUS Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
562 |
Figure 16‑11: IVUS Procedures by Country, Middle East, 2019 – 2029 |
563 |
Figure 16‑12: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
564 |
Figure 16‑13: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
565 |
Figure 16‑14: IVUS Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
566 |
Figure 16‑15: IVUS Procedures by Country, Africa, 2019 – 2029 |
567 |
Figure 16‑16: IVUS Catheter Market, Global, 2019 – 2029 |
568 |
Figure 16‑17: Units Sold by Region, IVUS Catheter Market, Global, 2019 – 2029 |
569 |
Figure 16‑18: Average Selling Price by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$) |
570 |
Figure 16‑19: Market Value by Region, IVUS Catheter Market, Global, 2019 – 2029 (US$M) |
571 |
Figure 16‑20: Leading Competitors, IVUS Catheter Market, Global, 2022 |
575 |